Polygenic immune susceptibility
Typical setting: Family clustering and variants in HLA, complement, interferon and lymphocyte pathways.
Multiple variants lower the threshold for loss of tolerance; rare early complement deficiencies strongly impair immune-complex clearance.
Hormonal and sex-linked influences
Typical setting: SLE is much more common in women, particularly during reproductive years.
Oestrogenic and X-linked immune effects alter B-cell survival and innate responses, but sex alone neither causes nor excludes disease.
Ultraviolet exposure
Typical setting: Sunlight preceding photosensitive rash or flare.
UV injury increases keratinocyte apoptosis and surface expression of nuclear antigens, feeding local and systemic autoimmunity.
Infection and immune activation
Typical setting: Viral or bacterial illness around symptom worsening.
Innate and adaptive activation can trigger flare, while immunosuppression makes infection a dangerous mimic that must be excluded.
Drug-induced lupus-like disease
Typical setting: Selected medicines produce lupus manifestations and characteristic antibody patterns.
Epigenetic or immune effects can break tolerance; the phenotype often differs from idiopathic SLE and may improve after withdrawal.
Smoking
Typical setting: Ongoing tobacco exposure.
Oxidative tissue injury and immune effects can worsen cutaneous disease, cardiovascular risk and response to some therapies.